Author

Daniel Ramos

Institution: Bial (Portugal)

Observed institution: Bial (Portugal)

ORCID: 0009-0004-0738-9968

Observed ORCID: 0009-0004-0738-9968

OpenAlex ID: A5130209101

Safety and efficacy of eslicarbazepine acetate for seizure prevention in patients with stroke at high risk of developing post-stroke epilepsy: a proof-of-concept, phase 2a, randomised, double-blind, placebo-controlled antiepileptogenesis trial

2026 · Matthias J Koepp, Eugen Trinka, et al. · The Lancet Neurology · 10

Opicapone in Parkinson’s patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study

2026 · Olga Klepitskaya, Peter A. LeWitt, et al. · Clinical Parkinsonism & Related Disorders · 1

Long-term safety profile of opicapone in patients with Parkinson’s disease and early fluctuations

2026 · Joaquim J. Ferreira, Fabrizio Stocchi, et al. · Frontiers in Neurology

Padrões Regionais na Prescrição de Antidiabéticos em Portugal: Oito Anos de Evidência do Mundo Real (2017 - 2024) (Estudo TREND-8 REGIONS)

2026 · Ana Rita Leite, Célia Ramalho, et al. · Acta Médica Portuguesa

Low Risk of Motor Complications in Early Parkinson’s Disease Patients Treated with Opicapone in the EPSILON Study: Effect of Levodopa Dose (P3-17.010)

2026 · Joaquim Ferreira, Olivier Rascol, et al. · Neurology

Works count: 5

Citation count: 11

H-index: 1

I10-index: 1